SCHEMBL6650786

SCHEMBL6650786

NC(=O)c1ccccc1Sc1nncs1

nearest known ligand 0.53

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SIRT1 Q96EB6 1/20 0.53
ALDH1A1 P00352 6/20 0.41
HSD17B10 Q99714 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
HPGD P15428 2/20 0.41
MAPK1 P28482 1/20 0.41
FBP1 P09467 1/20 0.39
MAPT P10636 3/20 0.39
USP2 O75604 1/20 0.39
TSHR P16473 2/20 0.38
GAA P10253 1/20 0.37
KDM4E B2RXH2 1/20 0.37
METAP2 P50579 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8923648 0.86 POLB (0.49) ALDH1A1HSD17B10L3MBTL1HPGDMAPK1
SCHEMBL3077375 0.76 SIRT1 (0.77) SIRT1ALDH1A1HSD17B10L3MBTL1HPGD
SCHEMBL6630237 0.76 SIRT1 (0.53) SIRT1ALDH1A1HSD17B10HPGDMAPK1
SCHEMBL6633843 0.73 SIRT1 (0.53) SIRT1ALDH1A1HSD17B10HPGDMAPK1
SCHEMBL3379802 0.70 BCAT2 (0.49) ALDH1A1HSD17B10L3MBTL1HPGDMAPK1
SCHEMBL31226904 0.70 BCAT2 (0.49) ALDH1A1HSD17B10L3MBTL1HPGDMAPK1
SCHEMBL6629448 0.70 SIRT1 (0.57) SIRT1ALDH1A1HSD17B10HPGDMAPK1
SCHEMBL6647601 0.70 SIRT1 (0.53) SIRT1ALDH1A1HSD17B10HPGDMAPT
SCHEMBL1030659 0.70 SIRT1 (1.00) SIRT1ALDH1A1HSD17B10L3MBTL1HPGD
SCHEMBL14891741 0.69 FLT3 (0.47) ALDH1A1HSD17B10L3MBTL1MAPK1FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1480977-A2 SUBSTITUTED ARYL COMPOUNDS FOR TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2004-12-01 EP disclosed
WO-2003070728-A2 AZABICYCLO-SUBSTITUTED BENZOYLAMIDES AND THIOAMIDES FOR TREATMENT OF CNS-RELATED DISORDERS PHARMACIA & UPJOHN COMPANY (US) 2003-08-28 WO disclosed